Divine Aleru, Microbiome Signatures Research Coordinator

This study analyzed vaginal microbiota diversity in women with V using molecular techniques. It identified key V-associated bacteria and emphasized the need for molecular diagnostics and microbiome-targeted therapies.

This study examines vaginal microbiome recovery after metronidazole treatment for V. Findings show delayed microbiota stabilization, L. iners dominance post-treatment, and the need for improved diagnostic tools to predict V recurrence.

This study used high-resolution sequencing to analyze bacterial communities in women with V. Findings reveal distinct microbial associations, diagnostic inconsistencies, and racial differences in V prevalence, highlighting the need for microbiome-targeted therapies and improved diagnostic tools.

This review explores bacterial vaginosis, focusing on microbial imbalances, immune responses, and diagnostic challenges. It highlights the need for microbiome-based treatments and improved diagnostics to reduce recurrence and improve V management.

This study identifies bacterial vaginosis-associated species, improving V diagnostics and treatment strategies through metagenomic sequencing.

This review explores bacterial vaginosis, emphasizing its recurrence, microbial associations, and treatment challenges. It highlights the need for microbiome-based therapies, standardized diagnostic criteria, and potential partner treatment to reduce reinfection. The findings underscore the importance of improved strategies for long-term V management.

This review explores bacterial vaginosis recurrence, emphasizing microbial persistence, reinfection, and partner treatment. It highlights the need for improved therapeutic strategies, including antimicrobial and microbiome-focused approaches, to reduce recurrence and improve long-term cure rates.

This review explores the competing hypotheses behind bacterial vaginosis (V), emphasizing microbial shifts, racial disparities, and sexual transmission. Key findings suggest V may be sexually transmitted and driven by Gardnerella vaginalis biofilms, necessitating novel treatment strategies beyond standard antibiotics. Understanding V pathogenesis is essential for improving prevention and care.

This review explores bacterial vaginosis (V), emphasizing microbial shifts, diagnostic challenges, and treatment strategies. It highlights the role of biofilms, emerging molecular diagnostics, and microbiome-based therapies like probiotics and vaginal microbiota transplantation, advocating for more effective, microbiome-informed approaches to managing V and its recurrence.

This review explores bacterial vaginosis diagnostics, highlighting traditional limitations and emerging molecular solutions. Advances in sequencing, metabolomics, and I-driven analysis offer promising improvements, enhancing diagnostic accuracy and treatment strategies.